# 01 — Preoperative Assessment & Checklist  
### Post-Mastectomy Breast Implant Revision  
### Multimodal Anesthesia & Surgical Workflow Protocol  
**Version 1.0 — December 2025**

---

# **Purpose**
This document outlines a clinically accurate, structured preoperative assessment for patients undergoing **post-mastectomy implant revision**. It integrates surgical and anesthesia risk stratification, oncologic considerations, infection risk, and multimodal analgesia planning.

It is designed for educational use by anesthesia trainees, CRNAs, residents, and medical students.

---

# **1. Patient Identification & Background**

### **1.1 Demographics**
- Name: ____________________  
- Age: ______  
- Sex: Female  
- BMI: ______  

### **1.2 Surgical Indication**
Select all that apply:

- ☐ History of bilateral mastectomy  
- ☐ Implant malposition  
- ☐ Capsular contracture (Grade III–IV)  
- ☐ Suspected infection  
- ☐ Implant rupture  
- ☐ Chronic seroma  
- ☐ Implant removal prior to reconstruction  
- ☐ Pocket revision for symmetry  
- ☐ Size/style change  

### **1.3 Comorbidities**
- ☐ Hypertension  
- ☐ Diabetes  
- ☐ GERD  
- ☐ CAD / CHF  
- ☐ Asthma / COPD  
- ☐ CKD  
- ☐ Obesity  
- ☐ Coagulopathy  
- ☐ Psychiatric illness / anxiety  
- ☐ Chronic opioid use  
- **ASA Class**: I ☐  II ☐  III ☐  IV ☐  

---

# **2. Oncologic & Surgical History**

### **2.1 Cancer History**
- Year of mastectomy: ______  
- Breast cancer stage: ______  
- Prior radiation therapy: ☐ Yes  ☐ No  
- Prior chemotherapy: ☐ Yes  ☐ No  

### **2.2 Prior Reconstruction Details**
- Reconstruction type:  
  - ☐ Implant-based  
  - ☐ Tissue expander → implant  
  - ☐ Autologous flap (if relevant)  
- Implant type (if known):  
  - ☐ Silicone  ☐ Saline  ☐ Unknown  
- Pocket plane:  
  - ☐ Subpectoral  
  - ☐ Prepectoral  
  - ☐ Dual plane  

### **2.3 Prior Complications**
- ☐ Infection  
- ☐ Expander/implant failure  
- ☐ Seroma  
- ☐ Hematoma  
- ☐ Capsular contracture  
- ☐ Wound dehiscence  
- ☐ ADM failure or thinning  

---

# **3. Infection Risk Evaluation**

### **3.1 Current Signs/Symptoms**
- Fever ☐  
- Erythema ☐  
- Purulence ☐  
- Warmth ☐  
- Elevated WBC ☐  
- Recent antibiotics ☐  
- Pain out of proportion ☐  

If infection suspected:  
- Prepare for **culture** collection after explant.  
- Coordinate appropriate perioperative antibiotics.

---

# **4. Laboratory & Diagnostic Review**

### **Required**
- ☐ CBC  
- ☐ CMP  
- ☐ Pregnancy test (if applicable)  
- ☐ Hemoglobin A1c (diabetic)  
- ☐ Coagulation panel (if indicated)  

### **Optional**
- ☐ Breast ultrasound or MRI to confirm rupture  
- ☐ Prior operative reports  
- ☐ Microbiology cultures (previous episodes)  

---

# **5. Airway & Anesthesia Evaluation**

### **5.1 Airway Assessment**
- Mallampati: I ☐  II ☐  III ☐  IV ☐  
- Thyromental distance: ______ cm  
- Mouth opening: ______  
- Neck ROM limitations: ☐ Yes  ☐ No  
- Previous difficult airway: ☐ Yes  ☐ No  

### **5.2 PONV Risk Score (Apfel)**
- Female = 1  
- Non-smoker = 1  
- History of PONV/motion sickness = 1  
- Post-op opioids = 1  

**Score:** 0 ☐  1 ☐  2 ☐  3 ☐  4 ☐  
*≥ 3 → high risk; consider multimodal prophylaxis.*

### **5.3 Hemodynamic Considerations**
- Beta blocker therapy ☐  
- Baseline bradycardia (avoid dexmedetomidine bolus) ☐  
- Uncontrolled hypertension ☐  

---

# **6. Regional Anesthesia Eligibility (PECS I/II or Serratus)**

### **6.1 Contraindications**
- ☐ Local infection  
- ☐ Coagulopathy / anticoagulation  
- ☐ Patient refusal  
- ☐ Allergy to local anesthetic  
- ☐ Inability to lie flat  
- ☐ Severe respiratory compromise  

### **6.2 Benefits Discussed**
- Superior analgesia  
- Reduction in opioid requirement  
- Reduced PONV  
- Improved early mobility  

### **6.3 Plan**
- ☐ Proceed with PECS I + II  
- ☐ Proceed with Serratus block  
- ☐ Block not planned (patient preference)  
- ☐ Block contraindicated  

---

# **7. Anesthesia Pathway Selection**

### **Option 1 — Opioid-Free With Regional Block**
Best for:
- High PONV risk  
- Anxiety about opioid use  
- History of difficult pain control  
- Patient prefers maximal comfort  

### **Option 2 — Opioid-Free Without Block**
Best for:
- Needle-minimalization preference  
- Mild-to-moderate expected pain  
- Stable anxiety and pain profile  

### **Option 3 — Conventional Opioid-Based GA**
Best for:
- Contraindications to OFA  
- Patient request  
- Chronic opioid tolerance  
- Complex/salvage-case revision  

**Selected Pathway:**  
**1 ☐    2 ☐    3 ☐**  

---

# **8. Medication Strategy Review**

### **8.1 Multimodal Analgesia Plan**
- Pre-op acetaminophen ☐  
- Pre-op gabapentin ☐  
- Lidocaine infusion ☐  
- Dexmedetomidine infusion ☐  
- Ketamine microdose ☐  

### **8.2 Antibiotic Prophylaxis**
- Typically: **Cefazolin 2–3 g IV**  
- Allergy: **Clindamycin** or **Vancomycin**  
- Redose for long cases per institutional protocol  

---

# **9. Preoperative Checklist (Final)**
**Complete all before proceeding to OR:**

- ☐ Identity confirmed  
- ☐ Consent signed (surgery + anesthesia + implants)  
- ☐ Pregnancy test (if applicable)  
- ☐ IV access secured  
- ☐ Antibiotics administered  
- ☐ Pre-op analgesia administered  
- ☐ Block performed (if applicable)  
- ☐ Vitals within acceptable limits  
- ☐ Surgical site marked  
- ☐ Implants and sizes reviewed  
- ☐ Equipment and airway tools confirmed  

---

# **10. Team Briefing**
**Discuss before incision:**

- Procedure steps and laterality  
- Use of drains  
- Block performed or not  
- Estimated blood loss  
- Communication plan for pain, hemodynamics, and airway  
- Expected challenges (capsular fibrosis, infection, scarring)  
- PONV prevention strategy  

---

# **End of Preoperative Assessment Document**
